|
Leading article
B2 The
medicines maze
PJ 2007;279:(suppl) B2
PDF (30K)
|
|
Plenary session
B5 Real
risks and perceived risks in focus Speakers
at the first plenary session of the conference looked at different
aspects of risk
Olivia
Timbs reports
PJ 2007;279:(suppl) B5
PDF (40K)
|
|
Science chairman
B3-4 Science chairman’s address:
joining up the risk versus benefit argument Modern
pharmacists need to be able to manage risk and benefit, Clive
Wilson says
PJ 2007;279:(suppl) B3-4
PDF (80K)
Science sessions
B8 From philosophy to patient
benefit Speakers at a session entitled “Drug
evaluation in the 21st century” looked at the successes
of drug development
Olivia Timbs and Ann Lewis report
PJ 2007;279:(suppl) B8
PDF (30K)
B14 Talk to patients in their own language Communicating
risk and benefit to patients was the theme of a session chaired by Joanne
Rule, of Cancerbackup
Harriet Adcock reports
PJ 2007;279:(suppl) B14
PDF (40K)
B15 Patient reporting of adverse events Patient
perception of medicines regulation and the need to encourage them to send in
reports of adverse events were discussed at a session led by the Medicines and
Healthcare Products Regulatory Agency
Hannah Pike reports
PJ 2007;279:(suppl) B15
PDF (40K)
B16 Involve patients in clinical trial design Economic
evaluation and the NICE appraisal process were discussed during a session chaired
by broadcaster Peter White
Harriet Adcock reports
PJ 2007;279:(suppl) B16
PDF (30K)
B17 OTC formulations unlikely to be of use
in preventing progression of mild AMD Participants
at a session on the emerging pattern of blindness in the West heard about developments
in prevention, care and cures
Tom Moberly reports
PJ 2007;279:(suppl) B17
PDF (30K)
B18 Detox — is it really good for you?
/ Risk mitigation in formulation development One
presentation revealed the truth about popular “detox” regimens and
products, and another gave suggestions on risk mitigation in formulation development
Gemma
Cleveland reports on two science of pharmacy sessions
PJ 2007;279:(suppl) B18
PDF (30K)
Science abstracts
B9-13 BPC science abstracts review This
year 170 science abstracts were presented at the British Pharmaceutical
Conference
Joseph Chamberlain reviews a selection
PJ 2007;279:(suppl) B9-13
PDF (180K)
|
|
BPC past and future
Treasures of the Royal Pharmaceutical Society's Collections
B22 Society treasues: a little bit
of history Briony Hudson, keeper of the Royal Pharmaceutical Society
museum collections, describes a collection of badges from past British
Pharmaceutical Conferences
PJ 2007;279:(suppl) B22
PDF (70K)
BPC 2008
B22 BPC 2008: “Adding years to life
and life to years”
PJ 2007;279:(suppl) B22
PDF (70K) |
|
Practice
chairman
B19-21 Practice chairman’s address:
To be or not to be taken? That is the question Theo
Raynor discusses research into information on patient leaflets and medicines
labels and calls for this to be improved and better used
PJ 2007;279:(suppl) B19-21
PDF (50K)
Practice sessions
B23 Patient priorities need to be considered Participants
at a session on communicating risks and benefits to people with special
needs heard that understanding patients is key
Tom Moberly reports
PJ 2007;279:(suppl) B23
PDF (40K)
B26-27 Progress achieved with new pharmacy
contract but room for improvement A major
evaluation of the community pharmacy contract in England and Wales was
presented at BPC
Harriet Adcock and Tom Moberly report
PJ 2007;279:(suppl) B26-27
PDF (50K)
B28-29 The brave new world of pharmacy? Four
models of pharmacy services were put to a panel of experts in a Dragons' Den style
symposium
Harriet Adcock reports
PJ 2007;279:(suppl) B28-29
PDF (60K)
B30 Statin therapy — should we put public
health before individual choice? The benefits and
complications of statin therapy for the primary prevention of cardiovascular
disease (CVD)
were
discussed
in a practice session
Hannah Pike reports
PJ 2007;279:(suppl) B30
PDF (40K)
B31 Safety issues with OTC medicines / A dose
of specially formulated information Gemma
Cleveland reports on two sessions on safety issues associated with OTC
medicines and on
the NHS's new information prescription service
PJ 2007;279:(suppl) B31
PDF (40K)
B32 Issues regarding the safety of herbals Herbal
products may have medicinal effects but the industry is largely unregulated
Gemma Cleveland reports on what is being done to address this
PJ 2007;279:(suppl) B32
PDF (40K)
B33 Special interests: update on progress Beth
Taylor, national development lead for pharmacists with special interests at NHS
Primary Care Contracting, reports on the session on these pharmacists. Mrs Taylor
also spoke at the session, giving an overview of the initiative
PJ 2007;279:(suppl) B33
PDF (30K)
B34 Pharmacy in a secure environment — progress
and problems in prisons The health of people in
prisons, problems with their medicines, and progress with schemes such as “in-possession
medication” were discussed at a session on prison pharmacy.
Davan Eustace reports
PJ 2007;279:(suppl) B34
PDF (50K)
B35 Self-administration — what are the
benefits and where is the evidence? Participants
heard about self-administration from pharmacists working in mental health and
paediatrics, and also heard from a patient. They then had a lively debate about
whether self-administration should be an indicator in the Healthcare Commission's
health check
Hannah Pike reports
PJ 2007;279:(suppl) B35
PDF (40K)
B36 Informing children about medicines Challenges
of keeping children and young people well informed about their medicines were
discussed in a session entitled “What about the children?”
Hannah Pike reports
PJ 2007;279:(suppl) B36
PDF (40K)
B37-38 Introducing the idea of fair blame In
a session about professional regulation, presenters spoke about the legal and
practical implications of dispensing errors
Olivia Timbs reports
PJ 2007;279:(suppl) B37-38
PDF (50K)
Practice abstracts
B39-42 Pharmacy
practice research: a review This year's
British Pharmaceutical Conference included 85 pharmacy practice research
papers
Clare Bellingham reviews a selection
PJ 2007;279:(suppl) B39-42
PDF (70K)
|
| Conference on camera
B6-7, 24-25 Conference
on camera
PJ 2007;279:(suppl) B6-7, 24-25
PDF (410K) |